NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-289-2011-0-PCT-02 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF PCT PCT PCT/US2012/051299 Expired
NCI E-289-2011-0-EP-14 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF EP National Stage 12824638.6 Pending
NIDDK E-260-2012-0-US-01 Cyclopentane-Peptide Nucleic Acids For Qualitative And Quantitative Detection Of Nucleic Acids US 61/684,354 Abandoned
NIAID E-222-2012-0-US-01 USE OF P47 FROM PLASMODIUM FALCIPARUM (PFS47) OR PLASMODIUM VIVAX (PVS47) AS A VACCINE OR DRUG SCREENING TARGETS FOR THE INHIBITION OF HUMAN MALARIA TRANSMISSION US 61/684,333 Abandoned
NCI E-052-2013-0-US-01 Use Of Argon As A Tissue Fixation Preservative US 61/684,204 Abandoned
NIA E-271-2006-0-US-04 METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF CANCER US DIV 13/587,515 10077296 Issued PDF
NIAID E-337-2004-0-JP-23 Recombinant MVA Viruses Expressing Clade A/G, Clade B, and C Modified HIV Env, Gag, And Pol Genes JP DIV 2012-180606 Abandoned
NIDDK E-067-2010-0-US-09 Inverse Agonists And Neutral Antagonists For The TSH Receptor US National Stage 13/579,251 9206154 Abandoned PDF
NIAID E-084-2010-0-US-03 Vaccine And Methods Of Use Against Strongyloides Stercoralis Infection US National Stage 13/575,987 9056068 Issued PDF
NIAID E-324-2005-3-US-04 CONFORMATIONALLY STABILIZED HIV ENVELOPE IMMUNOGENS US CON 13/585,700 8715686 Abandoned PDF
NIDDK E-116-2010-0-US-04 Chrysophaentin Antimicrobial Compounds That Inhibit FTSZ Protein US National Stage 13/578,803 8399689 Abandoned PDF
NICHD E-273-2010-0-US-02 A Sensitive And Robust Method To Characterize Cell Size Distributions From Magnetic Resonance Data US ORD 13/584,699 Abandoned
NIAID E-050-1997-1-US-18 METHOD AND DEVICE FOR DETECTING THE PRESENCE OF A SINGLE TARGET NUCLEIC ACID IN A SAMPLE US DIV 13/572,649 8563275 Abandoned PDF
NICHD E-168-2009-0-PCT-02 Spin Echo Sequences For Diffusion Weighted Imaging of Moving Media PCT PCT PCT/US2012/050303 Expired
NHLBI E-037-2011-0-US-01 Development Of A Novel HDL Based Hydrophobic Drug Delivery System Using Amphipathic Peptides US 61/682,057 Abandoned
NCI E-254-2005-2-IL-17 IL-15R-ALPHA ENCODING POLYNUCLEOTIDES, HOST CELLS, COMPOSITIONS, METHODS FOR EXPRESSION OF IL-15 AND IL-15R-ALPHA AND USES THEREOF IL DIV 221384 Issued
NCI E-215-2007-0-DE-14 Methods for determining a hepatocellular carcinoma subtype DE EP 12179595.9 Abandoned
NCI E-215-2007-0-ES-15 Methods for determining a hepatocellular carcinoma subtype ES EP 12179595.9 Abandoned
NIAID E-173-2004-1-US-11 Method for Using Adenoviral Vectors to Induce an Immune Response US CON 13/568,239 Abandoned
NHGRI E-055-2005-2-US-05 Methods And Use Of Farnesyl Transferase Inhibitors (FTIs) For Laminopathies, Cellular Aging, And Artherosclerosis US DIV 13/567,432 8691501 Abandoned PDF
NIA E-101-2010-0-US-03 Regulatory B Cells (TBregs) And Their Use US National Stage 13/577,226 9228171 Issued PDF
NCATS E-050-2012-0-US-01 Cyclodextrin For the Treatment of Lysosomal Storage Diseases US 61/679,668 Abandoned
NIAID E-202-2011-1-CN-03 PROTEASE-DEFICIENT BACILLUS ANTHRACIS CN National Stage 201280048638.1 Issued
NIAID E-202-2011-1-PCT-02 PROTEASE-DEFICIENT BACILLUS ANTHRACIS PCT PCT PCT/US2012/049321 Expired
NIAID E-189-2011-2-PCT-01 Treatment And Prevention Of Diseases Mediated By Microorganisms via Drug-Mediated Manipulation of the Eicosanoid Balance PCT PCT COMB PCT/US2012/049280 Expired
NIAID E-189-2011-2-IN-04 Treatment And Prevention Of Diseases Mediated By Microorganisms via Drug-Mediated Manipulation of the Eicosanoid Balance IN National Stage 238/MUMNP/2014 Abandoned
NIAID E-202-2011-1-EP-04 PROTEASE-DEFICIENT BACILLUS ANTHRACIS EP National Stage 12753853.6 Abandoned
NIAID E-189-2011-2-EP-03 Treatment And Prevention Of Diseases Mediated By Microorganisms via Drug-Mediated Manipulation of the Eicosanoid Balance EP National Stage 12746443.6 Abandoned
NIAID E-202-2011-1-IN-05 PROTEASE-DEFICIENT BACILLUS ANTHRACIS IN National Stage 1570/DELNP/2014 Abandoned
NIDA E-286-2015-0-US-01 Induction Of Highly Specific Antibodies To A Hapten But Not To A Carrier Peptide By Immunication US 61/633,996 Abandoned
NCI E-255-2012-0-US-01 Reversisble Regulation Of Intein Activity Through Engineered New Zinc Binding Domain US 61/678,303 Abandoned
NCI E-038-2012-1-US-01 THERAPEUTIC RNA SWITCHES COMPOSITIONS AND METHODS OF USE US 61/678,434 Abandoned
NCI E-551-2013-0-US-01 Combination Therapty For The Treatment Of Cancer US 61/677,379 Abandoned
NCI E-171-2011-0-PCT-02 Use of DPEP1 And TPX2 Expression For Evaluating Treatment Or Survival Time Of Patients With Pancreatic Ductal Adenocarcinoma PCT PCT PCT/US2012/048655 Abandoned
NICHD E-239-2012-0-US-03 A Method For Late Post Coital Contraception Using Ulipristal AcetateUS-201 US National Stage 13/575,918 Abandoned
NIA E-141-2000-0-US-14 Agents Useful For Reducing Amyloid Precursor Protein And Treating Dementia And Methods of Use Thereof US CON 13/559,186 8691864 Abandoned PDF
NCATS E-308-2009-0-US-03 Caspase Inhibitors US National Stage 13/575,273 9365612 Issued PDF
NCI E-188-2011-0-PCT-02 HIV Integrase Inhibitory Oxoisoindoline Sulfonamides PCT PCT PCT/US2012/048169 Expired
NIAID E-263-2005-0-US-06 Targeting Poly-gamma-glutamic acid to treat Staphylococcus Epidermidis and related infections US DIV 13/554,245 8623371 Issued PDF
NHGRI E-146-2012-0-US-01 Silent Mutation In Bcl-2-Like Protein 12 (BCL2L12) For Diagnosing and Treating Melanoma US 61/673,454 Abandoned
NHLBI E-175-2012-0-US-01 METHOD OF PREPARING SILICA-COATED NANODIAMONDS US 61/672,996 Abandoned
NICHD E-167-2009-3-US-01 Cholesterol Therapy For Autistic Spectrum Disorder US 61/672,933 Abandoned
NIAID E-124-2009-0-HK-11 Influenza Hemagglutinin And Neuraminidase Variants HK National Stage 12107057.1 Abandoned
NCI E-168-2011-0-IE-26 Methods and Compositions For Inhibiting Polyomavirus-Associated Pathology IE EP 12741191.6 Issued
NCI E-168-2011-0-HU-25 Methods and Compositions For Inhibiting Polyomavirus-Associated Pathology HU EP 12741191.6 Issued
NCI E-168-2011-0-GR-23 Methods and Compositions For Inhibiting Polyomavirus-Associated Pathology GR EP 12741191.6 Issued
NCI E-168-2011-0-DE-16 Methods and Compositions For Inhibiting Polyomavirus-Associated Pathology DE EP 12741191.6 Issued
NCI E-168-2011-0-IS-27 Methods and Compositions For Inhibiting Polyomavirus-Associated Pathology IS EP 12741191.6 Issued
NCI E-168-2011-0-HR-24 Methods and Compositions For Inhibiting Polyomavirus-Associated Pathology HR EP 12741191.6 Issued
NCI E-168-2011-0-CY-14 Methods and Compositions For Inhibiting Polyomavirus-Associated Pathology CY EP 12741191.6 Issued